3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
34
Carcinoma, Non-Small-Cell Lung
22
Carcinoma, Renal Cell
20
Neoplasm Metastasis
13
Carcinoma, Hepatocellular
10
Brain Neoplasms
8
Lung Neoplasms
7
Skin Neoplasms
6
Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Prostatic Neoplasms
5
Pancreatic Neoplasms
5
Kidney Neoplasms
5
Clear-cell metastatic renal cell carcinoma
5
Carcinoma, Transitional Cell
5
Uveal Melanoma
4
Ovarian Neoplasms
4
Myelodysplastic Syndromes
4
Multiple Myeloma
4
Glioblastoma
4
Carcinoma, Basal Cell
4
Carcinoma
4
Urinary Bladder Neoplasms
3
Urethral Neoplasms
3
Sarcoma
3
Recurrence
3
Mesothelioma
3
Liver Neoplasms
3
Leukemia, Myeloid, Acute
3
Histiocytoma, Malignant Fibrous
3
Interventions
Paclitaxel
10
Carboplatin
6
Bevacizumab
5
liposomal doxorubicin
4
Topotecan
3
Cyclophosphamide
3
pembrolizumab
2
oregovomab
2
olaparib
2
niraparib
2
fludarabine
2
Nivolumab
2
Drug Therapy
2
trastuzumab deruxtecan
1
rucaparib
1
ribociclib
1
palbociclib
1
mirvetuximab soravtansine
1
isoquercitrin
1
irinotecan sucrosofate
1
fludarabine phosphate
1
denileukin diftitox
1
anlotinib
1
Tinzaparin
1
Saline Solution
1
Propranolol
1
Preoperative Exercise
1
Platinum
1
Palliative Care
1
Neoadjuvant Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Ovarian Epithelial
×
Ipilimumab
×
90 days
×
Clear all
No trials found.